Efficacy Comparative Study Between Tears Again®, Opticol® and Optive®

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00893243
Recruitment Status : Completed
First Posted : May 5, 2009
Last Update Posted : May 5, 2009
Information provided by:
Hospital de Sao Sebastiao

Brief Summary:

Primary Purpose:

  • To compare the efficacy in treating dry eye syndrome in contact lens wearers or computer users of Tears Again® versus Opticol® versus Optive®

Secondary Purpose:

  • Subjective evaluation of symptomatology
  • Evaluation of preference in different kind of administration - spray versus monodoses versus multi-doses

Condition or disease
Dry Eye Syndrome

Study Type : Observational
Actual Enrollment : 27 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Efficacy Comparative Study Between Tears Again®, o Opticol® e o Optive® in Clinical and Symptomatology Treatment of Dry Eye Syndrome in Contact Lens Wearers and/or Computers Users

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tears
U.S. FDA Resources

1Tears Again/Control
4Tears Again/Opticol
5Tears Again/Optive

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Administrative staff of the hospital with more than 4 hours/day computer use and contact lens wearers

Inclusion Criteria:

  • Informed Consent signed
  • Age >18 years and < 55 years
  • Daily wearer of soft contact lens and/or daily (> 4 hours/day) computer user

Exclusion Criteria:

  • Dry eye Syndrome other than of evaporative etiology, according to DEWS
  • Ocular or systemic disease that can affect the normal tear film
  • Pregnancy or pregnancy risk (no contraceptive method), lactation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00893243

Serviço de Oftalmologia, Hospital de São Sebastião
Santa maria da Feira, Portugal, 4520-211
Sponsors and Collaborators
Hospital de Sao Sebastiao
Principal Investigator: Lilianne Duarte, MD Ophthalmologist
Study Director: José Salgado-Borges, PhD Ophthalmology Department Director

Responsible Party: Dr Lilianne Duarte, MD, Ophthalmologist Identifier: NCT00893243     History of Changes
Other Study ID Numbers: HSS-01-08
First Posted: May 5, 2009    Key Record Dates
Last Update Posted: May 5, 2009
Last Verified: May 2009

Additional relevant MeSH terms:
Keratoconjunctivitis Sicca
Dry Eye Syndromes
Pathologic Processes
Conjunctival Diseases
Eye Diseases
Corneal Diseases
Lacrimal Apparatus Diseases